Skip to search formSkip to main contentSkip to account menu

Fludilat

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
In 17 patients with peripheral arterial occlusive disease the influence of intra-veinously applicated Bencyclane (Fludilat) on… 
1978
1978
Increased blood and plasma viscosity was found in patients with chronic arterial occlusion in comparison with healthy probands… 
1977
1977
1-Benzyl-1-(3-dimethylaminopropoxy)cycloheptane (bencyclane-hydrogen-fumarate; Fludilat) in a concentration of 10-2 M effects an… 
1977
1977
The effect of the following vasoactive substances, which are used in the treatment of peripheral arterial occlusive diseases, was… 
1977
1977
Fludilat (bencyclane-hydrogen-fumarate) increases the O2 consumption and CO2 production of a 10% bovine lens homogenate. An… 
1976
1976
In 50 patients suffering from local cerebral circulation disturbances the effects of bencyclan--administered intravenously in a… 
1976
1976
The quantitative determination of bencyclane from the biological material was carried out with the aid of a combined… 
1975
1975
Bencyclan (Fludilat), used therapeutically as a vasodilator drug, exerts a distinct negative inotropic and chronotropic action on… 
1975
1975
The platelet aggregation inhibiting effect of N-[3-(1-benzyl-cycloheptyloxy)-propyl]-N,N-dimethyl-amine (bencyclan, Fludilat) was…